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 There’s been a lot of excitement about the new gene-editing tool CRISPR-Cas9. 
Discussion of the technology has largely focused on its precision, accuracy, customizability, and 
affordability. But the CRISPR-Cas system from which the technology was derived has a 
fascinating life of its own. The work of Eugene V. Koonin’s lab is mapping the rich histories of 
CRISPR-Cas systems in microbial populations. In “CRISPR: A New Principle of Genome 
Engineering Linked to Conceptual Shifts in Evolutionary Biology,” Koonin argues that 
fundamental research studying adaptive immune mechanisms has (among other things) 
illuminated “fundamental principles of genome manipulation.” I think Koonin’s discussion 
provides important philosophical insights for how we should understand the significance of 
CRISPR-Cas systems, and the technologies derived from them. Yet the analysis he provides is 
only part of a larger story that fully captures the biological significance that CRISPR-Cas 
systems represent. There is also a human element to the CRISPR-Cas story that concerns its 
development as a technology. Accounting for the human history of CRISPR-Cas reveals that the 
story Koonin provides requires greater nuance. I’ll show how CRISPR-Cas technologies are not 
“natural” genome editing systems but are partly artifacts of human ingenuity. Furthermore, I’ll 
argue that when it comes to the story of CRISPR-Cas, fundamental and applied research are 
importantly intertwined.  
 CRISPR-Cas systems are encoded in the DNA of microbial populations and can function 
as adaptive immune mechanisms. These systems consist of a suite of Cas proteins and a CRISPR 
array. Ideally, the CRISPR array contains genetic information from past encounters with invasive 
parasites. Koonin helpfully describes the CRISPR-Cas immune defense as having three stages: 
“1) adaptation, 2) expression/processing, and 3) interference.” In the adaptation stage, a distinct 
set of Cas proteins cleave out a portion of DNA from foreign genetic invaders and insert it into 
the CRISPR array as a spacer. Typically, the CRISPR array consists of numerous spacers from 
diverse invaders. During the expression/processing stage, the full CRISPR array is transcribed 
and distinct Cas proteins process the transcript into many smaller CRISPR RNAs (crRNAs). And 
finally, the interference stage is when the crRNAs identify genetic material with a matching 
spacer sequence, marking it for degradation by yet another set of Cas proteins. It is possible for 
genetic spacers to come from the system’s own genome. When this happens, the CRISPR-Cas 
system can target the host organism which it originally evolved to protect; thereby compromising 
the organism’s fitness. 
  One of Koonin’s central points is that open-ended exploration (what he calls 
fundamental research) of CRISPR-Cas systems has shed light on a basic principle of genome 
manipulation. Comparative genomic research has uncovered longstanding coevolutionary 
relationships between mobile genetic elements (viruses, plasmids, and transposons) and microbes 
containing CRISPR-Cas systems. Many of the Cas proteins that serve as defenses against genetic 
parasites in microbial immune systems are homologous to proteins that serve as offensive 
“weapons” in the very parasites that threaten to infect microbes (Koonin et al. 2017). It appears 
that microbes have developed what Koonin calls a “guns for hire” strategy where offensive 
2 | P a g e  
 
functional modules employed by infectious pathogens are recruited and exapted to serve as part 
of a host’s immune defense. Many of the functional modules that have been incorporated into 
CRISPR-Cas systems help make it an effective immune defense by enabling the precise 
rearrangement of genomic information. According to Koonin, this is what makes CRISPR-Cas a 
“naturally evolved genome editing toolkit.” The “guns for hire” strategy is not unique to the 
immune mechanisms of microbes, however. The author argues that many molecular mechanisms 
distinctive for their ability to precisely target and rearrange genomic information – such as, 
toxin-antitoxin systems, restriction-modification modules, piRNA machinery, etc. – are 
evolutionarily linked to mobile genetic elements in prokaryotes and eukaryotes.  
 Appreciation of CRISPR-Cas’ evolutionary significance is certainly indispensable for 
understanding how it has become an effective genome editing mechanism; however, our 
understanding of the CRISPR-Cas technology requires a bit more nuance. Most molecular 
technologies were, at one point in scientific history, components of naturally evolved systems. 
Prior to becoming a technology, biologists modify naturally evolved components to engineer a 
product that helps meet human needs. This very much describes the applied research programs 
that made CRISPR-Cas9 into the gene editing tool. When it comes to gene-editing, biologists 
value improved observational abilities, greater control, and more precise ways to intervene on a 
wide range of living systems. Many of the modifications done to CRISPR-Cas systems are 
attempts to make progress towards these goals. When developers of the CRISPR-Cas9 
technology adapted the Cas9 protein to carry a signal that ensures its transport into the nucleus of 
eukaryotic cells, biologists expanded what was biologically possible for CRISPR-Cas9. Now 
CRISPR-Cas9 can operate in organisms beyond the microbial populations in which it evolved 
(Cong et al. 2013). A host of further modifications have simplified the mechanism and improved 
its accuracy (Jinek et al. 2012). Some of the capacities that CRISPR-Cas technologies now 
possess are abilities that the naturally evolved systems were unlikely to develop independently of 
human intervention. Thus, the CRISPR-Cas9 system used by researchers in the lab is not a 
“naturally evolved genome editing toolkit.” Instead it is, in part, an artifact of human ingenuity.  
 The applied research programs that develop and use CRISPR-Cas technologies have the 
potential for advancing our knowledge of living organisms in at least two ways. First, it is 
common for researchers to discover new things about the naturally evolved mechanism from 
which a technology is derived. Indeed, this has already happened for the CRISPR-Cas9 
technology. Efforts to expand and enhance the capabilities of the Cas9 nuclease resulted in 
discovery of critical amino acid substitutions that enhance its activities (Kleinstiver et al. 2015). 
This knowledge has been used in conjunction with protein imaging techniques to enrich models 
of Cas9’s structure and function. Second, advancements in technology can make the study of 
complex biological systems more tractable. CRISPR-Cas9 has made the study of gene 
function(s) in living organisms by means of knockout studies a more affordable and facile 
experimental approach (Doench 2018). Technologies often expand what is biologically possible 
in laboratory settings. In doing so, they unlock new research avenues – even avenues in 
fundamental research – by making previously unobservable phenomena available for study.   
 As Koonin acknowledges, there is disproportionate institutional support for applied 
research programs. Increasingly, funding for fundamental research that engages in open-ended 
exploration is lost to applied research that holds promise for future commercial products. The 
multimillion dollar industry that sells and develops CRISPR-Cas technologies is an illustrative 
example of applied research receiving considerable amounts of funding. To add insult to injury, 
it is largely the applied side of CRISPR-Cas research that has captured the attention and 
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imagination of many scientists, journalists, and science fiction writers. (There’s even a popular 
action film entitled “Rampage” featuring CRISPR-Cas9 technology as a major plot device!) Yet 
as Koonin points out, the CRISPR-Cas9 technology was only possible with the aid of 
fundamental research.  
 One can acknowledge the problems of lopsided support for applied research and still 
appreciate that the story of CRISPR is not “primarily about research into fundamental biological 
mechanisms.” When it comes to CRISPR-Cas, fundamental and applied research are intertwined. 
The products of applied research often make fundamental research possible and fundamental 
research is often crucial for applied research to generate new products. The restriction enzymes 
and genome sequencing techniques that aided in open-ended exploration of the CRISPR-Cas 
system are, in part, technological products of applied research programs (Lander 2016). And, as 
Koonin has illustrated, fundamental research in the biological sciences has been crucial for 
identifying a host of naturally evolved components – like CRISPR-Cas, green fluorescent 
protein, RNAi, restriction enzymes, and more – whose capabilities are amenable to use and 
development as experimental tools. There may be good reasons for distinguishing between 
fundamental and applied research; however, their inherent entanglement means that both are 
crucial for our understanding of scientific and technological progress.  
 Biological technologies are philosophically interesting because of how they’re made and 
what they make possible. The molecular tools of biology often require feats of human ingenuity 
to transform naturally evolved components into partially artificial products. The products of this 
type of research program are often necessary for the success of fundamental research programs. 
Furthermore, the making of molecular tools also generates new insights into the naturally 
evolved component(s) from which the technology is derived. This means that an adequate 
understanding of a biological technology requires an appreciation of both the component’s 
natural and engineered history. The CRISPR-Cas technologies are no exception. 
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